// App-Quantinova.ai

1259 : A Multi-Center Study for Validation of a New Assay for Anti-Melanoma Differentiation-Associated Gene 5 (MDA5) Autoantibody

Researchers

Presenter

  • Shinji Sato

Principal Investigators

  • Akihiro Murakami

  • Akiko Kuwajima

  • Kazuhiko Takehara

  • Tsuneyo Mimori

  • Atsushi Kawakami

  • Michiaki Mishima

  • Takafumi Suda

  • Mariko Seishima

  • Manabu Fujimoto

  • Masataka Kuwana

Medical Centers

  • Dept of Rheum & Clinical Immun, Kyoto Univ Grad Schl of Med, Kyoto, Japan

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan

  • Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan

  • Department of Hematology, Kumamoto University School of Medicine, Kumamoto, Japan

  • Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamtsu, Japan

  • Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan

  • Department of Radiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

  • Dermatology, Kanazawa University, Kanazawa, Japan

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan

Locations

  • Japan

Companies

  • Medical & Biological

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Idiopathic interstitial pneumonias

  • Lupus

  • Interstitial lung disease

  • Rheumatoid arthritis

  • Scleroderma

  • juvenile polymyositis

  • Inflammatory Arthritis

  • Melanoma

  • Polymyositis and dermatomyositis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim